Limitations On Direct-To-Consumer Tests In Md. And NY

Law360, New York (July 8, 2016, 11:35 AM EDT) -- Direct-to-consumer laboratory testing, also known as direct access testing, permits consumers to order laboratory tests directly from a laboratory and eliminates the involvement of a health care professional. Direct-to-consumer genetic testing refers to genetic tests that are marketed directly to consumers. The tests can range from basic cholesterol or vitamin level testing to screening for parasites and disease. In some cases, specimen collection can be as simple as swabbing the inside of the cheek from the comforts of home. Recently, Kalorama Information, a pharmaceutical-industry research firm, said the U.S. market for direct-to-consumer genetic testing and routine laboratory testing was valued at $131 million in 2015, up from $15 million in 2010, and the market is expected to grow past $350 million by 2020.[1] The tests are primarily sold online or through multilevel marketing networks....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!